Month: April 2019
Gut Microbiome Connected to Effectiveness of Immunotherapies for Cancer
A growing amount of research shows that the gut microbiome has a dramatic affect on anti-tumor immunity. Just how the intestinal microbiota limits tumor expansion has remained somewhat elusive. This new study, published in Nature Commutations, shows why certain immune checkpoint inhibitors, used in cancer treatment, don’t always work. It’sRead
Physical Activity Maintains Weight Loss More than Diet
A new study from the University of Colorado Anschutz Health and Wellness Center (AHWC) at the CU Anschutz Medical Campus revealed physical activity does more to maintain substantial weight loss than diet. The study, published in the March issue of Obesity, was selected as the Editor’s Choice article. The objectiveRead
Is Functional Medicine Becoming a Commodity?
A commodity is defined as any “basic” good or service that is produced to meet a marketplace demand. Commodities are, well, commonplace—interchangeable, and indistinguishable from other products or services of the same type. Functional medicine should never be considered indistinguishable; widely accessible? Yes. Indistinguishable? No. I am deeply concerned thatRead
FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and itsRead
